221 related articles for article (PubMed ID: 10698693)
1. Neutral sphingomyelinase activity dependent on Mg2+ and anionic phospholipids in the intraerythrocytic malaria parasite Plasmodium falciparum.
Hanada K; Mitamura T; Fukasawa M; Magistrado PA; Horii T; Nishijima M
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):671-7. PubMed ID: 10698693
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium falciparum phospholipase C hydrolyzing sphingomyelin and lysocholinephospholipids is a possible target for malaria chemotherapy.
Hanada K; Palacpac NM; Magistrado PA; Kurokawa K; Rai G; Sakata D; Hara T; Horii T; Nishijima M; Mitamura T
J Exp Med; 2002 Jan; 195(1):23-34. PubMed ID: 11781362
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase.
Arenz C; Gartner M; Wascholowski V; Giannis A
Bioorg Med Chem; 2001 Nov; 9(11):2901-4. PubMed ID: 11597471
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of a magnesium-dependent neutral sphingomyelinase from bovine brain.
Bernardo K; Krut O; Wiegmann K; Kreder D; Micheli M; Schäfer R; Sickman A; Schmidt WE; Schröder JM; Meyer HE; Sandhoff K; Krönke M
J Biol Chem; 2000 Mar; 275(11):7641-7. PubMed ID: 10713073
[TBL] [Abstract][Full Text] [Related]
5. Short-term magnesium deficiency upregulates ceramide synthase in cardiovascular tissues and cells: cross-talk among cytokines, Mg2+, NF-κB, and de novo ceramide.
Altura BM; Shah NC; Shah G; Zhang A; Li W; Zheng T; Perez-Albela JL; Altura BT
Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H319-32. PubMed ID: 21984552
[TBL] [Abstract][Full Text] [Related]
6. Sphingomyelinase and membrane sphingomyelin content: determinants ofProximal tubule cell susceptibility to injury.
Zager RA; Burkhart KM; Johnson A
J Am Soc Nephrol; 2000 May; 11(5):894-902. PubMed ID: 10770967
[TBL] [Abstract][Full Text] [Related]
7. Neutral sphingomyelinase inhibitor scyphostatin prevents and ceramide mimics mechanotransduction in vascular endothelium.
Czarny M; Schnitzer JE
Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1344-52. PubMed ID: 15142848
[TBL] [Abstract][Full Text] [Related]
8. Alterations in erythrocyte membrane phospholipid organization due to the intracellular growth of the human malaria parasite, Plasmodium falciparum.
Maguire PA; Prudhomme J; Sherman IW
Parasitology; 1991 Apr; 102 Pt 2():179-86. PubMed ID: 1852485
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase.
Luberto C; Hassler DF; Signorelli P; Okamoto Y; Sawai H; Boros E; Hazen-Martin DJ; Obeid LM; Hannun YA; Smith GK
J Biol Chem; 2002 Oct; 277(43):41128-39. PubMed ID: 12154098
[TBL] [Abstract][Full Text] [Related]
10. Interfacial regulation of bacterial sphingomyelinase activity.
Jungner M; Ohvo H; Slotte JP
Biochim Biophys Acta; 1997 Feb; 1344(3):230-40. PubMed ID: 9059513
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol-3,5-Bisphosphate is a potent and selective inhibitor of acid sphingomyelinase.
Kölzer M; Arenz C; Ferlinz K; Werth N; Schulze H; Klingenstein R; Sandhoff K
Biol Chem; 2003 Sep; 384(9):1293-8. PubMed ID: 14515991
[TBL] [Abstract][Full Text] [Related]
12. Modification of host cell membrane lipid composition by the intra-erythrocytic human malaria parasite Plasmodium falciparum.
Hsiao LL; Howard RJ; Aikawa M; Taraschi TF
Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):121-32. PubMed ID: 2001227
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of neutral sphingomyelinase from Helicobacter pylori.
Chan EC; Chang CC; Li YS; Chang CA; Chiou CC; Wu TZ
Biochemistry; 2000 Apr; 39(16):4838-45. PubMed ID: 10769141
[TBL] [Abstract][Full Text] [Related]
14. In vitro effects of fat, FA, and cholesterol on sphingomyelin hydrolysis induced by rat intestinal alkaline sphingomyelinase.
Liu JJ; Nilsson A; Duan RD
Lipids; 2002 May; 37(5):469-74. PubMed ID: 12056588
[TBL] [Abstract][Full Text] [Related]
15. Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells.
Chen Y; Xu SC; Duan RD
Lipids Health Dis; 2015 Oct; 14():130. PubMed ID: 26493087
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a sphingomyelinase activity in Saccharomyces cerevisiae.
Ella KM; Qi C; Dolan JW; Thompson RP; Meier KE
Arch Biochem Biophys; 1997 Apr; 340(1):101-10. PubMed ID: 9126282
[TBL] [Abstract][Full Text] [Related]
17. Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activity.
Wu J; Nilsson A; Jönsson BA; Stenstad H; Agace W; Cheng Y; Duan RD
Biochem J; 2006 Feb; 394(Pt 1):299-308. PubMed ID: 16255717
[TBL] [Abstract][Full Text] [Related]
18. Effects of gentamicin on sphingomyelinase activity in cultured human renal proximal tubular cells.
Ghosh P; Chatterjee S
J Biol Chem; 1987 Sep; 262(26):12550-6. PubMed ID: 3040755
[TBL] [Abstract][Full Text] [Related]
19. Lipid transport in Plasmodium.
Haldar K
Infect Agents Dis; 1992 Oct; 1(5):254-62. PubMed ID: 1344664
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the neutral pH-optimum sphingomyelinase from rat brain: inhibition by copper II and ganglioside GM3.
Lister MD; Crawford-Redick CL; Loomis CR
Biochim Biophys Acta; 1993 Jan; 1165(3):314-20. PubMed ID: 8418889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
